PICTET ASSET MANAGEMENT SA 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-03 11:43 am Sale |
2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
PICTET ASSET MANAGEMENT SA | 0 0.000% |
-100,773 (Position Closed) |
Filing |
| 2021-02-10 11:37 am Purchase |
2020-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
PICTET ASSET MANAGEMENT SA | 100,773 5.250% |
100,773 (New Position) |
Filing |